Asia Pacific Ocular Drug Delivery Market Growth and Analysis by 2028

Historic Data: 2019-2020 | Base Year: 2021 | Forecast Period: 2022-2028

Asia Pacific Ocular Drug Delivery Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (Implantable Ocular Drug Delivery Systems, Particulate Drug Delivery Systems, Nano-Particle Drug Delivery System, and Others), Formulation Type (Liposomes and Nanoparticles, Solution, Emulsion, Suspension, and Ointment), Disease Type (Glaucoma, Diabetic Retinopathy, Dry Eye Syndrome, Macular Degeneration, Cataract, Diabetic Macular Edema, and Others), and End User (Hospitals, Ophthalmic Clinics, and Ambulatory Surgical Centers)

Report Date : Nov 2021
Report Code : TIPRE00025781

Category : Life Sciences
Status : Published

Available Report Formats :
No. of Pages : 145

Page Updated: Nov 2021

Analysis Strategic Insights Market Drivers Regional Insights Report Scope Recent Developments FAQs

The ocular drug delivery market in Asia Pacific is expected to grow toUS$ 5,608.56 million by 2028 from US$ 3,234.93 million in 2021. The market is estimated to grow at a CAGR of 8.2% from 2021 to 2028.

Several players operating in the ocular drug delivery market are developing and launching innovative products. The strategy of development and launch of new products helps companies to cater to a broad customer base. For instance, in June 2020, Senju Pharmaceutical Co., Ltd. and Otsuka Pharmaceutical Co., Ltd. announced the launch of a new combination ophthalmic solution, AILAMIDE Combination Ophthalmic Suspension, for the treatment of glaucoma and ocular hypertension. Additionally, in May 2019, Menicon Co., Ltd launched Menicon Bloom Myopia Control Management System. Menicon Bloom Night therapy includes the overnight wearing of a specifically designed reverse geometry orthokeratology contact lens—manufactured in hyper oxygen-permeable Menicon Z rigid material that guarantees ideal corneal oxygenation for comfortable contact lens wear. Such developments and launches of new products are emerging as a key trend in the ocular drug delivery market.

The 2019 novel coronavirus (2019-nCoV), officially named COVID-19 by the WHO, has spread to more than 170 countries, including China prompting the WHO to declare the disease as a global pandemic. COVID-19 has had a tremendous impact on eye care delivery across the Asia Pacific region. In Bangladesh, all routine elective eye surgeries were postponed. Only emergency eye treatment was conducted only at outpatient departments. Moreover, patients were allowed to go to hospital only in the case of emergency. Similarly in India, outreach eye health services stopped largely thus impacting the rural communities. All elective surgeries were postponed. Non-cataract conditions like diabetic retinopathy and glaucoma patients affected due to break in follow-ups. Additionally, COVID-19 is having a tremendous impact on eye care in the Maldives. Due to the lock down people are not able to travel from one place to the other. Air and sea transport is at standstill and people from the outlying islands are not able to visit the nearest centre for eye care. A few centers in the capital Male are offering online consultations to patients. However, this has its limitations and healthcare professionals cannot do refractions online and a detailed anterior segment and posterior segment examinations is also not possible. Thus, COVID 19 is having a significant impact on the quality and quantity of eye care in the Maldives.

With the new features and technologies, companies can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the ocular drug delivery market. The Asia Pacific ocular drug delivery market is expected to grow at a good CAGR during the forecast period.
25481-img1

This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Asia Pacific Ocular Drug Delivery Market Segmentation

Asia Pacific Ocular Drug Delivery Market – By Technology

Implantable Ocular Drug Delivery Systems
Particulate Drug Delivery Systems
Nano-Particle Drug Delivery System
Others

Asia Pacific Ocular Drug Delivery Market – By Formulation Type

Solution
Ointment
Suspension
Emulsion
Liposomes and Nanoparticles

Asia Pacific Ocular Drug Delivery Market – By Disease type

Cataract
Dry Eye Syndrome
Macular Degeneration
Glaucoma
Diabetic Retinopathy
Diabetic Macular Edema
Others

Asia Pacific Ocular Drug Delivery Market – By End User

Hospitals
Ophthalmic Clinics
Ambulatory Surgical Centers

Asia Pacific Ocular Drug Delivery Market – By Country

Japan
China
India
South Korea
Australia
Rest of APAC

Asia Pacific Ocular Drug Delivery Market – Companies Mentioned

AbbVie Inc.
Bausch Health Companies Inc.
Novartis AG
Clearside Biomedical, Inc
Taiwan Liposome Company, Ltd.

Asia Pacific Ocular Drug Delivery Report Scope

Report Attribute	Details
Market size in 2021	US$ 3,234.93 Million
Market Size by 2028	US$ 5,608.56 Million
Global CAGR (2021 - 2028)	8.2%
Historical Data	2019-2020
Forecast period	2022-2028
Segments Covered	By Technology Implantable Ocular Drug Delivery Systems Particulate Drug Delivery Systems Nano-Particle Drug Delivery System By Formulation Type Liposomes and Nanoparticles Solution Emulsion Suspension Ointment By Disease Type Glaucoma Diabetic Retinopathy Dry Eye Syndrome Macular Degeneration Cataract Diabetic Macular Edema By End User Hospitals Ophthalmic Clinics Ambulatory Surgical Centers
Regions and Countries Covered	Asia-Pacific China India Japan Australia Rest of Asia-Pacific
Market leaders and key company profiles	AbbVie Inc. Bausch Health Companies Inc. Novartis AG Clearside Biomedical, Inc. Taiwan Liposome Company, Ltd.

Research Manager

Mrinal Kerhalkar

Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

What are the Asia Pacific Ocular Drug Delivery Market report deliverables?

Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
PEST and SWOT Analysis
Market Size Value / Volume - Global, Regional, Country
Industry and Competitive Landscape
Excel Dataset

Recent Reports

Testimonials

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.

The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

YUKIHIKO ADACHI CEO, Deep Blue, LLC.

We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.

PIYUSH NAGPAL Sr. Vice President, High Beam Global

I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.

Jean-Herve Jenn Chairman, Future Analytica

This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.

John Suzuki President and Chief Executive Officer, Board Director, BK Technologies

The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.

Ran Kedem Partner, Reali Technologies LTDs

Reason to Buy